secwatch / observer
8-K filed June 12, 2024, 7:59 PM ET ticker VERA CIK 0001831828
leadership confidence high sentiment neutral materiality 0.30

Vera Therapeutics appoints Christy Oliger to board; grants 25K share options

Vera Therapeutics, Inc.

item 5.02

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-24-159935
form_type
8-K
ticker
VERA
cik
0001831828
company_name
Vera Therapeutics, Inc.
filed_at
2024-06-12T23:59:59+00:00
discovered_at
2026-05-14T18:03:20.541323+00:00
generated_at
2026-06-01T04:54:17.570959+00:00
sec_items
["5.02"]
event_type
leadership
sentiment
neutral
materiality_score
0.3
calibrated_materiality_score
0.3
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-24-159935
json_url
https://secwatch.observer/filing/0001193125-24-159935.json
markdown_url
https://secwatch.observer/filing/0001193125-24-159935.md
text_url
https://secwatch.observer/filing/0001193125-24-159935.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/d843919d8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christy Oliger

Director
VERA · Vera Therapeutics, Inc.
Effective
2024-06-07
Filed
June 12, 2024, 7:59 PM ET
On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Source-grounded claims

aae6323f53

Christy Oliger was appointed as Director at Vera Therapeutics, Inc..

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

SEC 8-K Item 5.02 confidence 1.0 SEC evidence

Comparable filings

GOOD

Gladstone Commercial elects George Stelljes as director; board expands to eight

GLADSTONE COMMERCIAL CORP June 2, 2026, 8:45 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Comparable filing

On June 1, 2026, the Board of Directors (the “Board”) of Gladstone Commercial Corporation (the “Company”) elected George “Chip” Stelljes, III to the Board, effective June 1, 2026.

Filing page SEC filing

GAIN

Gladstone Investment Elects George Stelljes to Board, Expands to 8 Directors

GLADSTONE INVESTMENT CORPORATION\DE June 2, 2026, 8:45 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Comparable filing

On June 1, 2026, the Board of Directors (the “Board”) of Gladstone Investment Corporation (the “Company”) elected George “Chip” Stelljes, III to the Board, effective June 1, 2026.

Filing page SEC filing

GLAD

Gladstone Capital elects George 'Chip' Stelljes as independent director, board expands to eight

GLADSTONE CAPITAL CORP June 2, 2026, 8:45 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Comparable filing

elected George "Chip" Stelljes, III to the Board, effective June 1, 2026.

Filing page SEC filing

OLD DOMINION ELECTRIC COOPERATIVE

Director Belvin Williamson Jr. resigns from Old Dominion Electric Cooperative board, effective July 28, 2026

OLD DOMINION ELECTRIC COOPERATIVE June 2, 2026, 8:06 AM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Comparable filing

On May 28, 2026, Belvin Williamson, Jr. notified us that he will resign from the board of directors of Old Dominion Electric Cooperative, effective as of July 28, 2026.

Filing page SEC filing

PAGP

Plains GP Holdings announces CAO succession: Montgomery promoted, Herbold retiring

PLAINS GP HOLDINGS LP June 2, 2026, 6:05 AM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Comparable filing

effective September 1, 2026, Russ Montgomery will be promoted to the position of Vice President, Accounting and Chief Accounting Officer of Plains All American GP LLC, the general partner of PAA, and PAA GP Holdings LLC, the general partner of PAGP.

Filing page SEC filing

PAA

Plains All American announces CAO retirement and Montgomery promotion effective Sep 1, 2026

PLAINS ALL AMERICAN PIPELINE LP June 2, 2026, 6:03 AM ET leadership Items 5.02

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Comparable filing

Chris Herbold, who previously served as Senior Vice President, Finance and Chief Accounting Officer of PAA and PAGP, is retiring from the company on August 31, 2026.

Filing page SEC filing

AHCO

AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant

AdaptHealth Corp. June 1, 2026, 9:02 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Comparable filing

the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026

Filing page SEC filing

HON

Honeywell appoints Jill Evanko to Board of Directors, effective June 1, 2026

HONEYWELL INTERNATIONAL INC June 1, 2026, 8:12 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02 same event type: leadership similar materiality

This filing

On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.

Comparable filing

Ms. Jillian Evanko, 48, Chief Executive Officer of Duravant LLC, has been appointed to serve as an Independent Director on the Company’s Board of Directors and a member of the Audit Committee, in each case, effective June 1, 2026.

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-24-159935
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.